247 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Fill in a starting date and a closing date for the period your query is about: DD-MM-YYYY

You can select a specific type of a publication you are looking for, such as press releases or speeches

Abemaciclib (Verzenios®) for the treatment of metastatic breast cancer

Zorginstituut Nederland has completed its assessment of abemaciclib (Verzenios®) for the treatment of metastatic breast cancer. ...

Report | 07-03-2019

Axicabtagene ciloleucel (Yescarta®) for the treatment of adult patients with recurring or refractory diffuse large-cell B-cell lymphoma (DLBCL) and primary mediastinal large-cell B-cell lymphoma (PMBCL)

Zorginstituut Nederland carried out an assessment of the medicinal product axicabtagene ciloleucel (axi-cel, Yescarta®) for the ...

Report | 07-03-2019

Tisagenlecleucel (Kymriah®) for the treatment of DLBCL

Zorginstituut Nederland has completed its assessment of tisagenlecleucel (Kymriah®) for the treatment of DLBCL. Due to its ...

Report | 07-03-2019

Patiromer (Veltassa®) for the treatment of hyperkalaemia in adults

Zorginstituut Nederland has carried out an assessment whether patiromer (Veltassa®) is interchangeable with a medicinal product ...

Report | 25-02-2019

Tisagenlecleucel-T (Kymriah®) for the treatment of ALL

Zorginstituut Nederland carried out an assessment of the medicinal product tisagenlecleucel-T (Kymriah®) for the treatment of ...

Report | 18-12-2018

Lesinurad (Zurampic®) for the treatment of hyperuricaemia in gout patients

Zorginstituut Nederland carried out an assessment whether lesinurad (Zurampic®) is interchangeable with any product that is ...

Report | 04-12-2018

Letermovir (Prevymis®) in cases of adult CMV-seropositive recipients of an allogenic haemotopoietic stem cell transplant (HSCT)

Zorginstituut Nederland has carried out an assessment whether letermovir (Prevymis®) is interchangeable with a medicinal product ...

Report | 27-11-2018

Final report FAIR Data feasibility assessment

This is the final report of the FAIR Data part of the FAIR Data and Personal Health Train feasibility assessment. In this ...

Report | 31-10-2018

Final report on the Personal Health Train feasibility assessment

This is the final report of the FAIR Data part of the feasibility assessment on FAIR Data & the Personal Health Train (PHT). In ...

Report | 31-10-2018

Zinnige Zorg in-depth phase appropriate post-treatment surveillance of patients with non-melanoma skin cancer or actinic keratosis - letter to Minister

As part of the Zinnige Zorg programme, Zorginstituut Nederland started the in-depth phase of appropriate post-treatment ...

Letter | 24-10-2018